Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-08

Clinical Trial Update: Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether rapid withdrawal of steroids influences subclinical markers of rejection in kidney transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 4 | Status: TERMINATED